Dynamite (CAM)
Dynamite Medical Marijuana Strain Review
From: Colorado Alternative Medicine
Grade: A
Type: Mostly Indica (an F4 Grapefruit crossed back into the BC Grapefruit mother, from Next Generation Seeds)
Price: $50/8th
Appearance: (8.5/10) Very nice dense stocky structure with an outwardly frosty pale green sheen. Rather good harvest timing as well, with about 10% amber trichomes visible.
Aroma: (8.5/10) Sweet-and-sour grapefruit in the jar, turns to an even sharper yet fresh-smelling citrus-soil after being ground up… fairly pungent and complex.
Taste: (7/10) Earthy citrus with a pine tinge was the flavor here, though it didn’t last beyond the first 3 hits and got a bit woody towards the end. Fairly smooth, yet expansive, it burned to a very light gray ash, indicating a quality flush.
Effects: Felt strongly right away in the eyes and sinuses, this one also has a very strong pulsing narcotic body effect that left our reviewers with big smiles and the desire to simply relax. Couchlock, appetite stimulation, and a completely relaxed body are the hallmarks of any strong Indica, and this one fits the bill perfectly.
Duration: Long, 2.5 – 3 hours
Medicinal Traits: (We are NOT doctors – personal opinion ONLY) Total mental and body relaxation, appetite stimulation, anti-depression, anti-anxiety, sleep aid, possible ocular relief, hypertension.
Overall: A surprising favorite amongst the staff, this potent medicinal Indica has a place with any patient who struggles with pain or appetite especially, but it’s also a great choice for anyone later in the day or when being physically active isn’t required. Watch the dosage with this one though, as it can put you to sleep if you’re not careful! Altogether, it’s a superb medical strain with a pleasing citrusy taste/smell package.
Related Reviews and Strains
Tags: A, CAM, cannabis review, Colorado Alternative Medicine, denver, dynamite, Grapefruit, Indica, marijuana reviews, medical marijuana strain review, smoke report, strain info, Strain Review
Trackback from your site.







Comments (2)